B. Metzler Seel. Sohn & Co. Ag Novartis Ag Transaction History

B. Metzler Seel. Sohn & Co. Ag

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$92.57 - $107.37 $178,382 - $206,901	-1,927 Reduced 42.18%	2,642 $281,000
Q1 2024 May 15, 2024	SELL	$95.27 - $108.47 $198,352 - $225,834	-2,082 Reduced 31.3%	4,569 $441,000
Q4 2023 Feb 13, 2024	BUY	$92.27 - $101.54 $66,249 - $72,905	718 Added 12.1%	6,651 $671,000
Q2 2023 Aug 11, 2023	BUY	$92.52 - $104.91 $68,094 - $77,213	736 Added 14.16%	5,933 $598,000
Q1 2023 May 10, 2023	SELL	$80.03 - $92.81 $208,638 - $241,955	-2,607 Reduced 33.41%	5,197 $478,000
Q4 2022 Feb 13, 2023	SELL	$75.55 - $92.52 $46,614 - $57,084	-617 Reduced 7.33%	7,804 $707,000
Q3 2022 Nov 14, 2022	BUY	$74.61 - $87.26 $220,099 - $257,417	2,950 Added 53.92%	8,421 $640,000
Q2 2022 Aug 12, 2022	BUY	$80.52 - $93.75 $440,524 - $512,906	5,471 New	5,471 $462,000

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of B. Metzler Seel. Sohn & Co. Ag, based on Form 13F filings with the SEC.

Stay updated on B. Metzler Seel. Sohn & Co. Ag with notifications on news.